National Institute of Allergy and Infectious Diseases
Link to NIAID Home Page Link to NIAID Home Page Link to NIH Home Page
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

About NIAID
 Overview
 Organization
  Organizational Charts
  Office of the Director
  DAIDS
  DAIT
  DCR
  DEA
  DIR
  DMID
  VRC
 Director's Page
 Working at NIAID
 Finding People
 Visitor Information


Division of Acquired Immunodeficiency Syndrome (DAIDS)

HIV/AIDS Network Clinical Trials Units (CTU) and Clinical Research Sites (CRS) 

As of December 1, 2008

NIAID has funded the following Clinical Trials Units (CTU) and their associated Clinical Research Sites (CRS) to implement the clinical research plans of one or more of the six NIAID-funded HIV/AIDS Clinical Trials Networks (see listing to the right).

The HIV/AIDS Clinical Trials Networks and their CTU/CRS will pursue clinical trials to address the highest priorities in HIV/AIDS research, including: (1) vaccine research and development; (2) translational research/drug development; (3) optimization of clinical management, including co-morbidities; (4) microbicides; (5) prevention of mother-to-child transmission of HIV; and (6) prevention of HIV infection.

Clinical Trials Units and Clinical Research Sites Listing (as of December 1, 2008):

back to top

 

NIAID-sponsored HIV/AIDS Clinical Trial Networks

AIDS Clinical Trials Group (ACTG)

HIV Vaccine Trials Network (HVTN)

HIV Prevention Trials Network (HPTN)

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT)

Microbicide Trials Network (MTN)

International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)

All NIAID-sponsored HIV/AIDS Clinical Trials Networks


Highlights

Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
Feb. 1, 2008

News Releases

HHS Release: U.S. Releases Updated Clinical Guidelines for HIV-Associated Opportunistic Infections
Apr. 16, 2009

Male Circumcision Reduces Risk of Genital Herpes and HPV Infection, but Not Syphilis
March 25, 2009

NIAID Media Availability: New Technology Opens Gateway to Studying HIV-Specific Neutralizing Antibodies
March 15, 2009

National Native HIV/AIDS Awareness Day
March 20, 2009

Special Announcements

Status of NIAID Adenovirus-based Vaccine Studies

Considerations for HIV Vaccine Clinical Trials in Adolescents

Guidance regarding HIV anti-retroviral treatment in developing countries

 
E-mail Icon E-mail this page
Print Icon Print this page
 

NIAID-sponsored HIV/AIDS Clinical Trial Networks

AIDS Clinical Trials Group (ACTG)

HIV Vaccine Trials Network (HVTN)

HIV Prevention Trials Network (HPTN)

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT)

Microbicide Trials Network (MTN)

International Network for Strategic Initiatives in Global HIV Trials (INSIGHT)

All NIAID-sponsored HIV/AIDS Clinical Trials Networks


Highlights

Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
Feb. 1, 2008

News Releases

HHS Release: U.S. Releases Updated Clinical Guidelines for HIV-Associated Opportunistic Infections
Apr. 16, 2009

Male Circumcision Reduces Risk of Genital Herpes and HPV Infection, but Not Syphilis
March 25, 2009

NIAID Media Availability: New Technology Opens Gateway to Studying HIV-Specific Neutralizing Antibodies
March 15, 2009

National Native HIV/AIDS Awareness Day
March 20, 2009

Special Announcements

Status of NIAID Adenovirus-based Vaccine Studies

Considerations for HIV Vaccine Clinical Trials in Adolescents

Guidance regarding HIV anti-retroviral treatment in developing countries